Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases

Andrew Mendiola, PhD named 2020 Berkelhammer Scholar

Unlocking the Drivers of Neuroinflammation in Neurodegenerative Disease

Illustration of amyloid plaques on a nerverticale cell.

MS researcher gets it in gear

Andrew Mendiola, PhD featured in Momentum, the official magazine of the National MS Society

Toxic Cell Atlas Guides New Therapies for Neurodegeneration

Gladstone researchers Jae Kyu Ryu, Katerina Akassoglou, and Andrew Mendiola developed a novel method to profile toxic immune cells in the brain, and used it to identify a therapeutic target for multiple sclerosis.

Tox-seq revealed subtypes of brain immune cells that produce toxic reactive oxygen in a mouse model of MS.